OUR MISSION
To develop safe and transformative molecular therapies for Congenital Disorders of Glycosylation and other genetic diseases.
Executive team
LEADERSHIP
Founded by scientists committed to turning CDG research into therapies
Marisa Brothwell, PhD
Co-founder, CEO
Kent Lai, PhD, MBA
Co-founder, CSO
Guided by leaders in metabolic genetics and gene therapy development
Scientific Advisory Board
ADVISORS
Nicola Longo, MD, PhD
Chief of Clinical Genetics, UCLA
Clayton Beard, PhD
Gene therapy R&D leader
Contact Us: marisa.brothwell@allelerxtherapeutics.com